# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000310158-19-000019
Filing Date
2019-05-08
Accepted
2019-05-08 16:34:31
Documents
95
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 1Q19 FORM 10-Q | mrk0331201910q.htm | 10-Q | 1672424
2 | EXHIBIT 31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO 1Q19 | exhibit311rule13a-14a15dx1.htm | EX-31.1 | 8658
3 | EXHIBIT 31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO 1Q19 | exhibit312rule13a-14a15dx1.htm | EX-31.2 | 8691
4 | EXHIBIT 32.1 SECTION 1350 CERTIFICATION OF CEO 1Q19 | exhibit321section1350certi.htm | EX-32.1 | 5192
5 | EXHIBIT 32.2 SECTION 1350 CERTIFICATION OF CFO 1Q19 | exhibit322section1350certi.htm | EX-32.2 | 5494
| Complete submission text file | 0000310158-19-000019.txt |  | 12444463

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | mrk-20190331.xml | EX-101.INS | 3887405
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20190331.xsd | EX-101.SCH | 66377
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20190331_cal.xml | EX-101.CAL | 108193
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20190331_def.xml | EX-101.DEF | 361771
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20190331_lab.xml | EX-101.LAB | 845544
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20190331_pre.xml | EX-101.PRE | 533863

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 19807166
SIC: 2834 Pharmaceutical Preparations